Ticker LaunchIPO lock-up expiration calendar
16 IPO lock-ups end in the next 30 days and 21 more in the 60 days after that; the largest company by market value at its IPO is Space Exploration Technologies Corp (SPCX), whose lock-up ends on Dec 9, 2026. Dates are read from each company's final prospectus.
Next 30 days
| Lock-up ends | Company | Symbol | IPO date | IPO price | Raised | Market cap at IPO | Lock-up | Lead-left |
|---|---|---|---|---|---|---|---|---|
| Tue Oct 20, 2026 | Yesway, Inc. | YSWY | Apr 23, 2026 | $20.00 | $280M | $1.22B | 180 days | Morgan Stanley |
| Tue Oct 20, 2026 | Elmet Group Co. | ELMT | Apr 23, 2026 | $14.00 | $120M | $403.9M | 180 days | Cantor |
| Sat Oct 24, 2026 | X-Energy, Inc. | XE | Apr 27, 2026 | $23.00 | $1.02B | $9.02B | 180 days | J.P. Morgan |
| Tue Oct 27, 2026 | Avalyn Pharma Inc. | AVLN | Apr 30, 2026 | $18.00 | $300M | $752.6M | 180 days | Morgan Stanley |
| Wed Oct 28, 2026 | Hemab Therapeutics Holdings, Inc. | COAG | May 1, 2026 | $18.00 | $301.5M | $795.5M | 180 days | Goldman Sachs |
| Wed Oct 28, 2026 | Seaport Therapeutics, Inc. | SPTX | May 1, 2026 | $18.00 | $254.9M | $954.5M | 180 days | Goldman Sachs |
| Tue Nov 3, 2026 | Rare Earths Americas, Inc. | REA | May 7, 2026 | $19.00 | $63.3M | $378.8M | 180 days | Cantor |
| Wed Nov 4, 2026 | Odyssey Therapeutics, Inc. | ODTX | May 8, 2026 | $18.00 | $279M | $849.1M | 180 days | J.P. Morgan |
| Wed Nov 4, 2026 | Suja Life, Inc. | SUJA | May 8, 2026 | $21.00 | $186.7M | $811.1M | 180 days | Goldman Sachs |
| Wed Nov 4, 2026 | Mobia Medical, Inc. | MOBI | May 8, 2026 | $15.00 | $150M | $496.3M | 180 days | BofA Securities |
| Tue Nov 10, 2026 | Cerebras Systems Inc. | CBRS | May 14, 2026 | $185.00 | $5.55B | $39.8B | 180 days | Morgan Stanley |
| Tue Nov 10, 2026 | Fervo Energy Co | FRVO | May 14, 2026 | $27.00 | $1.89B | $7.66B | 180 days | J.P. Morgan |
| Tue Nov 10, 2026 | GMR Solutions Inc. | GMRS | May 14, 2026 | $15.00 | $478.7M | — | 180 days | J.P. Morgan |
| Tue Nov 10, 2026 | EagleRock Land, LLC | EROK | May 14, 2026 | $18.50 | $320.1M | $2.41B | 180 days | Goldman Sachs |
| Wed Nov 11, 2026 | Blackstone Digital Infrastructure Trust Inc. | BXDC | May 15, 2026 | $20.00 | $1.75B | $1.75B | 180 days | Goldman Sachs |
| Tue Nov 17, 2026 | Lincoln International, Inc. | LCLN | May 21, 2026 | $20.00 | $421M | $2.04B | 180 days | Goldman Sachs |
31 to 90 days
| Lock-up ends | Company | Symbol | IPO date | IPO price | Raised | Market cap at IPO | Lock-up | Lead-left |
|---|---|---|---|---|---|---|---|---|
| Tue Dec 1, 2026 | Innio N.v. | INIO | Jun 4, 2026 | $27.00 | $2.43B | $20.25B | 180 days | Goldman Sachs |
| Tue Dec 1, 2026 | Liftoff Mobile, Inc. | LFTO | Jun 4, 2026 | $23.00 | $437M | $3.83B | 180 days | Goldman Sachs |
| Wed Dec 2, 2026 | Quantinuum Inc. | QNT | Jun 5, 2026 | $60.00 | $1.68B | $15.66B | 180 days | Joint (alphabetical) |
| Wed Dec 2, 2026 | Sunshine Silver Mining & Refining Co | SSMR | Jun 5, 2026 | $13.50 | $270M | $1.9B | 180 days | Morgan Stanley |
| Sun Dec 6, 2026 | WhiteHawk Minerals Corp. | WHK | Jun 9, 2026 | $26.00 | $200.2M | $695.4M | 180 days | Raymond James |
| Mon Dec 7, 2026 | Parabilis Medicines, Inc. | PBLS | Jun 10, 2026 | $20.00 | $670M | $2.33B | 180 days | BofA Securities |
| Mon Dec 7, 2026 | ERock, Inc. | EROC | Jun 10, 2026 | $21.50 | $600M | $4.72B | 180 days | Morgan Stanley |
| Tue Dec 8, 2026 | Forbright, Inc. | FRBT | Jun 11, 2026 | $18.00 | $142.2M | $894.4M | 180 days | Goldman Sachs |
| Wed Dec 9, 2026 | Space Exploration Technologies Corp | SPCX | Jun 12, 2026 | $135.00 | $75B | $1765.24B | 180 days (staged) | Goldman Sachs |
| Wed Dec 9, 2026 | Neutron Holdings, Inc. | LIME | Jul 2, 2026 | $25.00 | $173.9M | $1.6B | 160 days | Goldman Sachs |
| Tue Dec 15, 2026 | Kardigan, Inc. | KARD | Jun 18, 2026 | $16.00 | $400M | $1.43B | 180 days | J.P. Morgan |
| Tue Dec 15, 2026 | First Carolina Financial Services, Inc. | FCBM | Jun 18, 2026 | $12.50 | $68.8M | $378.1M | 180 days | Stifel |
| Wed Dec 23, 2026 | DPC Holdings PLC | DPC | Jun 26, 2026 | $33.00 | $919.3M | $4.79B | 180 days | Jefferies |
| Wed Dec 23, 2026 | DSC Holdings Ltd. | DSC | Jun 26, 2026 | $17.00 | $51M | $851.2M | 180 days | Deutsche Bank |
| Sat Dec 26, 2026 | Sinda Ltd. | SIND | Jun 29, 2026 | $12.00 | $213M | $1.79B | 180 days | Morgan Stanley |
| Mon Dec 28, 2026 | Bending Spoons S.p.A. | BSP | Jul 1, 2026 | $29.00 | $1.68B | $9.42B | 180 days | Goldman Sachs |
| Tue Dec 29, 2026 | ITG, Inc./DE/ | ITG | Jul 2, 2026 | $16.00 | $312.2M | $1.94B | 180 days | Morgan Stanley |
| Sun Jan 3, 2027 | Buda Juice, Inc. | BUDA | Jan 8, 2026 | $7.50 | — | $95M | 360 days | — |
| Tue Jan 12, 2027 | Csquare, Inc. | CSQR | Jul 16, 2026 | $21.00 | $1.05B | $3.26B | 180 days | Morgan Stanley |
| Tue Jan 12, 2027 | Standard Nuclear, Inc. | STDN | Jul 16, 2026 | $15.00 | $150M | $2.41B | 180 days | BofA Securities |
| Wed Jan 13, 2027 | Amaero Inc. | AMRO | Oct 15, 2026 | $4.25 | $20M | $121.3M | 90 days | Baird |
Further out
| Lock-up ends | Company | Symbol | IPO date | IPO price | Raised | Market cap at IPO | Lock-up | Lead-left |
|---|---|---|---|---|---|---|---|---|
| Sat Jan 23, 2027 | Scribe Therapeutics, Inc. | SCTX | Jul 27, 2026 | $15.00 | $128.7M | $263.7M | 180 days | Leerink Partners |
| Tue Jan 26, 2027 | Reformation Inc. | REF | Jul 30, 2026 | $15.00 | $142.2M | $886.1M | 180 days | J.P. Morgan |
| Wed Jan 27, 2027 | Jersey Mike's Subs Inc. | JMKE | Jul 31, 2026 | $23.00 | $1B | $7.31B | 180 days | Morgan Stanley |
| Wed Jan 27, 2027 | Apnimed, Inc. | APMD | Jul 31, 2026 | $16.00 | $192M | $637.2M | 180 days | Evercore ISI |
| Mon Feb 1, 2027 | Attovia Therapeutics, Inc. | ATTO | Aug 5, 2026 | $17.00 | $289M | $731.5M | 180 days | Morgan Stanley |
| Tue Feb 2, 2027 | Braveheart Bio, Inc. | BRVE | Aug 6, 2026 | $18.00 | $382.5M | $1.32B | 180 days | Goldman Sachs |
| Wed Feb 3, 2027 | Latigo Biotherapeutics, Inc. | LTGO | Aug 7, 2026 | $18.00 | $345.6M | $1.14B | 180 days | Goldman Sachs |
| Wed Feb 3, 2027 | BlossomHill Therapeutics, Inc. | BLSM | Aug 7, 2026 | $16.00 | $150M | $490.3M | 180 days | J.P. Morgan |
| Wed Feb 3, 2027 | Ticketplus Ltd. | TP | Aug 7, 2026 | $8.00 | $15M | $96.5M | 180 days | Bancroft |
| Mon Feb 8, 2027 | Vogenx, Inc. | VOGX | Aug 12, 2026 | $13.00 | $81.2M | $180.9M | 180 days | JonesTrading Institutional Services |
| Wed Feb 10, 2027 | Londian Wason New Energy Tech Inc. | FOIL | Aug 14, 2026 | $22.00 | $94.3M | $8.6B | 180 days | Huatai |
| Mon Feb 15, 2027 | Lyntris Inc. | LYNX | Aug 19, 2026 | $17.50 | — | $2.03B | 180 days | Evercore ISI |
| Wed Mar 17, 2027 | Electra Therapeutics, Inc. | ETRA | Sep 18, 2026 | $15.00 | $350M | $941.5M | 180 days | Jefferies |
| Sat Mar 20, 2027 | Orion180 Insurance Group Inc. | OIG | Sep 21, 2026 | $12.00 | $240M | $1.19B | 180 days | RBC Capital Markets |
| Sat Mar 27, 2027 | ADARx Pharmaceuticals, Inc. | ADRX | Sep 28, 2026 | $17.00 | $446.2M | $1.82B | 180 days | J.P. Morgan |
| Tue Mar 30, 2027 | Accelevation Holdings Corp. | ACCV | Oct 1, 2026 | $18.00 | $540M | $4.05B | 180 days | Morgan Stanley |
| Wed Mar 31, 2027 | Chilwa Minerals Ltd | CHWM | Oct 2, 2026 | $5.60 | $3.5M | $58.4M | 180 days | Maxim Group |
| Wed Apr 7, 2027 | TRex Bio, Inc. | TRXB | Oct 9, 2026 | $14.00 | $116.7M | $384.2M | 180 days | J.P. Morgan |
| Wed Apr 7, 2027 | Retension Pharmaceuticals, Inc. | RTSN | Oct 9, 2026 | $12.00 | $45M | $100M | 180 days | Guggenheim |
| Tue Apr 13, 2027 | Iambic Therapeutics, Inc. | IAM | Oct 15, 2026 | $16.00 | $150M | $758.4M | 180 days | J.P. Morgan |
| Wed Apr 14, 2027 | City Therapeutics, Inc. | CTY | Oct 16, 2026 | $18.00 | $200M | $931M | 180 days | Goldman Sachs |
Ended in the last 30 days
| Lock-up ends | Company | Symbol | IPO date | IPO price | Raised | Market cap at IPO | Lock-up | Lead-left |
|---|---|---|---|---|---|---|---|---|
| Sat Oct 17, 2026 | AEVEX Corp. | AVEX | Apr 20, 2026 | $20.00 | $320M | $2.23B | 180 days | Goldman Sachs |
| Wed Oct 14, 2026 | Alamar Biosciences, Inc. | ALMR | Apr 17, 2026 | $17.00 | $191.2M | $1.13B | 180 days | — |
| Wed Oct 14, 2026 | Kailera Therapeutics, Inc. | KLRA | Apr 17, 2026 | $16.00 | $625M | $1.98B | 180 days | J.P. Morgan |
| Tue Oct 13, 2026 | Arxis, Inc. | ARXS | Apr 16, 2026 | $28.00 | $1.13B | $1.78B | 180 days | Goldman Sachs |
| Thu Oct 8, 2026 | SK hynix Inc. | SKHY | Jul 10, 2026 | $149.00 | $26.51B | $108.6B | 90 days | Joint (alphabetical) |
| Mon Sep 28, 2026 | HMH Holding Inc | HMH | Apr 1, 2026 | $20.00 | $210.4M | $861.9M | 180 days | J.P. Morgan |
The lock-up end date is the IPO pricing date plus the lock-up period stated in the final prospectus (usually 180 days); shares can typically be sold from the next trading day. Many agreements allow earlier release, often after an earnings report or if the stock trades above a set price, and the banks can waive them. "Staged" means the prospectus also sets other release dates for some shares. The prospectus's Underwriting section has the exact terms; dates here are not investment advice.
By month
January 2025 February 2025 March 2025 April 2025 May 2025 June 2025 July 2025 August 2025 September 2025 October 2025 November 2025 December 2025 January 2026 February 2026 March 2026 April 2026 May 2026 June 2026 July 2026 August 2026 September 2026 October 2026 November 2026 December 2026 January 2027 February 2027 March 2027 April 2027
What is an IPO lock-up?
Before an IPO, the company's directors, officers and most existing shareholders agree with the underwriters not to sell their shares for a set period after the offering, most often 180 days. When the lock-up ends, those shares can be sold, which can add a large number of shares to the market. See also the IPO calendar for deals expected to price, and all US IPOs since 2019.
The free weekly recap
Every Monday: the IPOs that priced and filed, SPAC deals and closings, and what is expected to price this week, from the filings.